Chinese cosmetics group selling skincare brands, including acquired premium brand EviDenS de Beaute, mainly via e-commerce.
Chinese cosmetics group selling skincare brands, including acquired premium brand EviDenS de Beaute, mainly via e-commerce.
In one line: A Chinese e-commerce-led multi-brand cosmetics group.
Moat: narrow (brand, distribution). Strong livestream/e-commerce distribution capability across a multi-brand skincare portfolio.
Headquarters: Hangzhou, China · Employees: 2,082
Size SYoung (300740.SZ) is a China Consumer Staples company (Household/Personal Care) with a market value of $816M, the 2549th largest of 4,790 China companies the cockpit tracks. Shares closed at CN¥13.40 on 18 Nov 2026.
Performance Over six months the shares fell 48.2%, against +9.2% for the median peer and -20.0% for the China market (cap-weighted) — 2nd lowest of 21 in its peer set.
Growth Revenue grew 13.9% over the last twelve months (peer median +10.2%); the operating margin is 3.2% (peer median 9.8%).
Valuation It trades at 33.4× forward earnings against a peer median of 18.9× (4th most expensive of 20).
Price implies For today's price to make sense, revenue must grow about 14% a year for seven years (Req g). Recent delivered growth is +6%, so the hurdle is +8 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
Capital Return on invested capital runs 3.9 points below its cost of capital (10.1% WACC).
Next results Next results expected around 28 Apr 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | CN¥5.24B | CN¥4.97B | CN¥4.23B | CN¥4.48B | CN¥4.71B |
| Revenue growth | — | +17% | -6% | -5% | — |
| Gross profit | CN¥3.55B | CN¥3.18B | CN¥2.61B | CN¥2.56B | CN¥2.46B |
| EBITDA | n/a | CN¥328M | CN¥326M | CN¥460M | CN¥196M |
| Net income | CN¥113M | CN¥148M | CN¥110M | CN¥294M | CN¥125M |
| Free cash flow | CN¥480M | CN¥505M | -CN¥8.63M | CN¥86.8M | -CN¥275M |
| Capital expenditure | CN¥55.7M | CN¥69.4M | CN¥278M | CN¥178M | CN¥293M |
| Total debt | CN¥838M | CN¥1.60B | CN¥1.69B | CN¥1.45B | CN¥1.28B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| SYoung 300740.SZ | $816M | -48% | +14% | 3% | 33.4× | 14.0% |
| Proya Cosmetics 603605.SS | $2.87B | -13% | +2% | 13% | 10.9× | -5.3% |
| Yunnan Botanee Bio-Technology 300957.SZ | $1.69B | -33% | +7% | 9% | 19.1× | 2.6% |
| Guangdong Marubi Biotechnology 603983.SS | $1.62B | +9% | -6% | 2% | 45.5× | n/a |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 300740.SZ | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -28.7% | -3.5% | lowest of 21 |
| 6-month return | -48.2% | +9.2% | 2nd lowest of 21 |
| Distance from 52-week high | -52.7% | -33.6% | 4th lowest of 21 |
| Revenue growth (TTM) | +13.9% | +10.2% | 9th highest of 21 |
| Operating margin | 3.2% | 9.8% | 2nd lowest of 21 |
| Forward P/E | 33.4× | 18.9× | 4th most expensive of 20 |
| Growth the price implies (Req g, 7 yrs) | 14.0% | 4.3% | 6th most demanding of 18 |
| Growth delivered (Del g) | +6.1% | +8.9% | 6th lowest of 18 |
| Hurdle (Req g minus delivered) | +7.9 pp | -4.4 pp | 4th most demanding of 18 |
| ROIC minus cost of capital | -3.9 pp | +7.1 pp | lowest of 21 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| SYoung 300740.SZ | China | $816M | -48% | +14% | 3% | 33.4× | 14.0% | +6.1% |
| Galaxy Surfactants GALAXYSURF.NS | India | $845M | +22% | +30% | 9% | 17.6× | 18.5% | +13.7% |
| Cosmecca Korea 241710.KS | South Korea | $847M | +23% | +42% | 12% | 16.3× | n/a | n/a |
| Jyothy Labs JYOTHYLAB.NS | India | $762M | -9% | +5% | 8% | 40.8× | 34.5% | +8.9% |
| Milbon 4919.T | Japan | $743M | +48% | +8% | 14% | 25.7× | -3.3% | +8.2% |
| Dencare (Chongqing) Oral Care 001328.SZ | China | $912M | +13% | +10% | 11% | 27.9× | 3.7% | +10.8% |
| Hangzhou Haoyue Personal Care 605009.SS | China | $726M | -18% | +10% | 6% | 17.7× | 4.4% | +7.7% |
| Runben Biotechnology 603193.SS | China | $918M | -30% | +13% | 21% | 18.5× | 1.5% | +28.4% |
| Tongling Jieya Biologic Technology 301108.SZ | China | $933M | +56% | +24% | 5% | 52.5× | 28.5% | +0.8% |
| Noevir 4928.T | Japan | $978M | +7% | -3% | 28% | 20.4× | -12.8% | +4.1% |
| Shanghai Forest Cabin Cosmetics 2657.HK | Hong Kong | $1.04B | +15% | +74% | 18% | 11.8× | 11.3% | +49.0% |
| d'Alba Global 483650.KS | South Korea | $1.13B | -55% | +49% | 22% | 12.0× | -6.6% | +53.0% |
| Shanghai Chicmax Cosmetics 2145.HK | Hong Kong | $1.17B | -42% | +23% | 8% | 14.4× | -6.1% | +21.2% |
| Bajaj Consumer Care BAJAJCON.NS | India | $560M | -24% | +29% | 22% | 19.7× | 14.8% | +5.0% |
| PZ Cussons PZC.L | United Kingdom | $527M | +13% | +5% | 11% | 12.7× | -2.3% | -2.1% |
| Edgewell Personal Care EPC | United States | $1.30B | +67% | -10% | 7% | 14.2× | n/a | n/a |
| Chongqing Baiya Sanitary Products 003006.SZ | China | $1.35B | +27% | 0% | 3% | 37.3× | 28.8% | +22.8% |
| Intercos ICOS.MI | Italy | $1.43B | +12% | -5% | 9% | 18.9× | 4.3% | +11.5% |
| Qingdao Kingking Applied Chemistry 002094.SZ | China | $454M | -26% | +3% | 4% | n/a | n/a | n/a |
| Harbin Fuerjia Technology 301371.SZ | China | $1.51B | -39% | +28% | 20% | 21.4× | 7.5% | +3.6% |
| Tianjin Yiyi Hygiene Products 001206.SZ | China | $429M | -15% | -8% | 9% | 19.9× | 1.9% | +6.3% |